CBD 3Q26 adjusted EBITDA rises 17% to R$ 482 million vs. 3Q25

PUBT · 4d ago
CBD 3Q26 adjusted EBITDA rises 17% to R$ 482 million vs. 3Q25
  • CBD’s third-quarter 2026 adjusted consolidated net loss narrowed 33% from a year earlier to R$ 264 million.
  • Adjusted EBITDA rose 17% year over year to R$ 482 million.
  • The extrajudicial reorganization plan secured court approval, with issuance of new securities related to affected claims scheduled for December 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CBD - Companhia Brasileira de Distribuição published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.